ChristopherMirandaLoftusMD

Cerebrovascular Neurosurgery

Director (Acting) and Chief Medical Officer, OHT5 Office of Neurological and Physical Medicine Devices, OPEQ, CDRH, US Food and Drug Administration

Dr. Loftus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 1980 - 1985
New York Presbyterian Hospital (Columbia Campus)Internship, Transitional Year, 1979 - 1980
State University of New York Downstate Medical Center College of MedicineClass of 1979

PubMed

1 citations
Moyamoya angiopathy and developmental abnormalities: a neurosurgical perspective.
Christopher M. Loftus
Developmental Medicine and Child Neurology. 2021-02-01
2 citations
Postoperative Anticoagulation After Neurologic Surgery.
Joel Z. Passer, Christopher M. Loftus
Neurosurgery Clinics of North America. 2018-10-01
5 citations
Balloon-Occlusion Catheter Onyx Embolization of a Spinal Dural Arteriovenous Fistula Presenting with Subarachnoid Hemorrhage in a Pediatric Patient.
Dustin M. Hayward, Stephen J. Johans, Jordan Rosenblum, Christopher M. Loftus, William W. Ashley
Journal of Stroke and Cerebrovascular Diseases. 2016-04-01

FDA Approves VR System for Chronic Lower Back PainNovember 17th, 2021
FDA Authorizes Marketing of Virtual Reality System for Chronic Pain ReductionNovember 16th, 2021
A Drug-Free Rehabilitation System for Stroke SurvivorsSeptember 1st, 2021
Join now to see all